KRAS G12C mutation associated outcomes among patients with locally advanced non-small cell lung cancer.

e21079Background: Recent progress in targeted therapy includes the demonstration of promising anti-tumor activity and safety of a KRAS inhibitor in patients with advanced malignancies harboring the...